{"id":"tp-58797","type":"article-newspaper","title":"BrainStorm Cell Therapeutics Posts $0.68 Q3 Loss, Misses Estimate by $0.50","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58797","datePublished":"2026-11-16T21:14:11.000Z","dateModified":"2026-11-16T21:14:11.000Z","language":"en","abstract":"Cash, cash equivalents and restricted cash totaled about $350,000 at Sept. 30, 2026, up from about $240,000 a year earlier.","section":"Business","references":[]}